Persistent activation of NF-κB and IL-6/STAT3 signaling modifies splicing patterns, increases proteostatic burden, and upregulates ribosome biogenesis, thereby reinforcing the chronic microinflammatory state that promotes tumor initiation and progression [52,53,54]. The gene discussed is IL6; the disease is neoplasm.